Quipt Home Medical Corp. (QIPT)
NASDAQ: QIPT · Real-Time Price · USD
2.430
-0.040 (-1.62%)
Dec 5, 2025, 4:00 PM EST - Market closed
Quipt Home Medical Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Quipt Home Medical stock ranges from a low of $2.30 to a high of $4.00. The average analyst price target of $3.15 forecasts a 29.63% increase in the stock price over the next year.
Price Target: $3.15 (+29.63%)
Analyst Consensus: Buy
* Price targets were last updated on Aug 19, 2025.
Analyst Ratings
The average analyst rating for Quipt Home Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.7 → $2.3 | Hold | Maintains | $1.7 → $2.3 | -5.35% | Aug 19, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $6 → $4 | Strong Buy | Maintains | $6 → $4 | +64.61% | May 14, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $4 → $1.7 | Strong Buy → Hold | Downgrades | $4 → $1.7 | -30.04% | May 13, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +146.91% | Dec 20, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +188.07% | Aug 21, 2024 |
Financial Forecast
Revenue This Year
244.50M
from 245.92M
Decreased by -0.58%
Revenue Next Year
314.65M
from 244.50M
Increased by 28.69%
EPS This Year
-0.20
from -0.16
EPS Next Year
-0.06
from -0.20
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 259.4M | 327.0M | |
| Avg | 244.5M | 314.7M | |
| Low | 232.3M | 299.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 5.5% | 33.8% | |
| Avg | -0.6% | 28.7% | |
| Low | -5.5% | 22.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.14 | 0.11 | |
| Avg | -0.20 | -0.06 | |
| Low | -0.23 | -0.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.